Finance
China's Ministry of Finance is taking aim at local debt problems before tackling broader economic challenges

The 597-meter high Goldin Finance 117 Tower in Tianjin, China, started construction in September 2008, but still stands unfinished in this picture, taken Aug. 28, 2024.
Nurphoto | Nurphoto | Getty Images
BEIJING — China’s Ministry of Finance press briefing over the weekend underscored how it is focused on tackling local government debt problems, instead of the stimulus markets have been waiting for.
In his opening remarks on Saturday, Minister of Finance Lan Fo’an laid out four measures, starting with increasing support for local governments in resolving debt risks. It was only after he outlined those four points that Lan teased that the country was looking to increase debt and the deficit.
“The press conference is consistent with our view that addressing local government financing struggles is a priority,” Robin Xing, chief China economist at Morgan Stanley, and his team said in a report Sunday. They also expect that the central government will play a larger role in debt restructuring and housing market stabilization.
“However, we believe upsizing consumption support and social welfare spending will likely remain gradual,” the Morgan Stanley analysts said.
China’s real estate market slump has cut into a significant source of revenue for local governments, many of which struggled financially even before needing to spend on Covid-19 measures. Meanwhile, lackluster consumption and slow growth overall have multiplied calls for more fiscal stimulus.
The four policies announced by the Ministry of Finance are focused more on tackling structural issues, Chinese economic think tank CF40 said in a report Saturday.
“They are not specifically aimed at addressing macroeconomic issues such as insufficient aggregate demand or declining price levels through Keynesian-style fiscal expansion,” the report said, in reference to expectations of greater government intervention.
CF40 estimates China does not need additional fiscal funding to achieve the full-year growth target of around 5%, as long as the spending that it has already announced happens by the end of the year.
Local governments drag on domestic demand
Finance Minister Lan on Saturday did say the central government would allow local governments to use 400 billion yuan ($56.54 billion) in bonds to support spending on payroll and basic services.
He added that a large plan to address local governments’ hidden debt would be announced in the near future, without specifying when. Lan claimed that hidden debt levels at the end of 2023 were half what they were in 2018.
Historically, local governments were responsible for more than 85% of expenditure but only received about 60% of tax revenue, Rhodium Group said in 2021.
Constrained local government finances have “contributed to the downward pressure on prices,” the International Monetary Fund said in an Aug. 30 report on China.
The core consumer price index, which strips out more volatile food and energy prices, rose by 0.1% in September, compared to a year ago. That’s the slowest since February 2021, according to the Wind Information database.
To Morgan Stanley, resolving local government debt problems is a “critical step” toward halting the declining trend of prices — almost just as important as stimulus directed at boosting demand.
Waiting for another meeting
After a flurry of policy announcements in the last few weeks, investors are looking ahead to a meeting of China’s parliament, expected at end of the month. China’s legal process requires it to approval national budget changes. The meeting last year, which ended on Oct. 24, oversaw a rare increase in the fiscal deficit to 3.8%, from 3%, according to state media.
Analysts are divided over the specific amount of fiscal support that is needed, if any.
“Whether it’s 2 trillion [yuan] or 10 trillion, for us, it actually doesn’t make so much of a difference,” Vikas Pershad, fund manager at M&G Investments, said Monday on CNBC’s “Squawk Box Asia.” “Our bet on China is a multi-year bet. The Chinese equities are too low in valuation.”
He emphasized the policy direction is “on the right path,” regardless of the stimulus size.
Pershad has talked about buying opportunities in Chinese stocks since January but he said Monday that the latest flurry of activity from the region hasn’t made him any more active in the sector.
China’s policymakers have generally remained conservative. Beijing did not hand out cash to consumers after the pandemic, unlike Hong Kong or the U.S.
Julian Evans-Pritchard, head of China economics at Capital Economics, said at least 2.5 trillion yuan of additional funding is needed to keep growth around 5% this year and next.
“Anything less than that, and I think the risk really is the economy just continues to slow next year given all the structural headwinds that it faces,” he said Monday on CNBC’s “Squawk Box Asia.”
Evans-Pritchard insisted that fiscal policy is more critical for addressing the latest economic slump since China’s other support tools have previously included real estate and credit, which are not as effective this time.
“It’s hard to put a specific number on it because obviously there’s a lot of talk of recapitalizing the banks, dealing with the existing debt problems among the local governments,” he said. “If a lot of the additional borrowing goes into those areas it actually does not stimulate current demand that significantly.”
— CNBC’s Sonia Heng contributed to this report.

Finance
Private equity firm will finance Harvard research lab, in possible template for future

A private equity firm has stepped in to finance a biological research lab at Harvard University, administrators said Monday, while also launching a biotech alongside it that will develop new therapies for metabolic conditions.
As Harvard grapples with severe financing cuts undertaken by the Trump administration, some university officials believe the unusual arrangement could be at least one model to fund other academic research in the future.
Under the deal announced Monday, İş Private Equity, a Turkish firm, has committed $39 million to a laboratory run by Gökhan Hotamışlıgil, a professor of genetics and metabolism at the T.H. Chan School of Public Health. The firm, which is a branch of Turkey’s İşbank Group, also plans to invest an undisclosed amount of money in any drug candidates that come out of Hotamışlıgil’s laboratory and are moved into a new biotech called Enlila.
It’s a relatively modest deal, in the scope of investment banking. But the collaboration provides much-needed capital at a time when the model for funding scientific research has been thrown into chaos.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
View All Plans
Finance
Kinatico Ltd’s (ASX:KYP) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Kinatico (ASX:KYP) has had a rough month with its share price down 7.7%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Specifically, we decided to study Kinatico’s ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder’s equity.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
The formula for return on equity is:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity
So, based on the above formula, the ROE for Kinatico is:
3.2% = AU$840k ÷ AU$26m (Based on the trailing twelve months to December 2024).
The ‘return’ is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each A$1 of shareholders’ capital it has, the company made A$0.03 in profit.
See our latest analysis for Kinatico
So far, we’ve learned that ROE is a measure of a company’s profitability. We now need to evaluate how much profit the company reinvests or “retains” for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don’t necessarily bear these characteristics.
It is hard to argue that Kinatico’s ROE is much good in and of itself. Not just that, even compared to the industry average of 5.0%, the company’s ROE is entirely unremarkable. Despite this, surprisingly, Kinatico saw an exceptional 44% net income growth over the past five years. We reckon that there could be other factors at play here. Such as – high earnings retention or an efficient management in place.
Next, on comparing with the industry net income growth, we found that Kinatico’s growth is quite high when compared to the industry average growth of 24% in the same period, which is great to see.
Finance
Mutuum Finance Short-Term Price Forecast: Will It Be The Next Crypto To Hit $1?
-
West1 week ago
Battle over Space Command HQ location heats up as lawmakers press new Air Force secretary
-
Technology1 week ago
There are only two commissioners left at the FCC
-
News1 week ago
A former police chief who escaped from an Arkansas prison is captured
-
World1 week ago
Ukraine: Kharkiv hit by massive Russian aerial attack
-
News1 week ago
Major union boss injured, arrested during ICE raids
-
World1 week ago
Colombia’s would-be presidential candidate shot at Bogota rally
-
Technology1 week ago
Xbox console games are suddenly showing up inside the Xbox PC app
-
Technology1 week ago
Massive DMV phishing scam tricks drivers with fake texts